guest ::
| Home > Publications database > Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease > print |
| Home > Publications database > Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease > print |
| 001 | 904372 | ||
| 005 | 20230123101907.0 | ||
| 024 | 7 | _ | |a 10.1016/j.neurobiolaging.2021.06.014 |2 doi |
| 024 | 7 | _ | |a 0197-4580 |2 ISSN |
| 024 | 7 | _ | |a 1558-1497 |2 ISSN |
| 024 | 7 | _ | |a 2128/32247 |2 Handle |
| 024 | 7 | _ | |a 34284259 |2 pmid |
| 024 | 7 | _ | |a WOS:000691900600011 |2 WOS |
| 037 | _ | _ | |a FZJ-2021-05942 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Pfeil, Julia |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Unique regional patterns of amyloid burden predict progression to prodromal and clinical stages of Alzheimer's disease |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2021 |b Elsevier Science |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1667372284_15986 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Although beta-amyloid (Aβ) positivity has shown to be associated with higher risk of progression to Alzheimer's disease (AD) in mild cognitive impairment (MCI), information on the time to conversion to manifest dementia cannot be readily deduced from this binary classification. Here, we assessed if regional patterns of Aβ deposition measured with 18F-florbetapir may serve as biomarker for progression risk in Aβ-positive cognitively normal (CN) and MCI patients, including clinical follow-up data and cerebrospinal fluid (CSF) biomarkers. Voxel-wise group comparisons between age and sex-matched Aβ-positive groups (i.e., CN-stables [n = 38] vs. CN-to-MCI/AD progressors [n = 38], MCI-stables [n = 104] versus MCI-to-AD progressors [n = 104]) revealed higher Aβ burden in precuneus, subcortical, and parietal regions in CN-to-MCI/AD progressors and cingulate, temporal, and frontal regions in MCI-to-AD progressors. Importantly, these regional patterns predicted progression to advanced stages on the AD spectrum in the short and the long-term beyond global Aβ burden and CSF biomarkers. These results suggest that distinct regional patterns of Aβ burden are a valuable biomarker for risk of disease progression in CN and MCI. |
| 536 | _ | _ | |a 5253 - Neuroimaging (POF4-525) |0 G:(DE-HGF)POF4-5253 |c POF4-525 |f POF IV |x 0 |
| 536 | _ | _ | |a 5254 - Neuroscientific Data Analytics and AI (POF4-525) |0 G:(DE-HGF)POF4-5254 |c POF4-525 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Hoenig, Merle C. |0 P:(DE-Juel1)178642 |b 1 |
| 700 | 1 | _ | |a Doering, Elena |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a van Eimeren, Thilo |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Drzezga, Alexander |0 P:(DE-Juel1)177611 |b 4 |
| 700 | 1 | _ | |a Bischof, Gerard Nisal |0 P:(DE-Juel1)166265 |b 5 |
| 700 | 1 | _ | |a Initiative, Alzheimer's Disease Neuroimaging |0 P:(DE-HGF)0 |b 6 |
| 773 | _ | _ | |a 10.1016/j.neurobiolaging.2021.06.014 |g Vol. 106, p. 119 - 129 |0 PERI:(DE-600)1498414-3 |p 119 - 129 |t Neurobiology of aging |v 106 |y 2021 |x 0197-4580 |
| 856 | 4 | _ | |y Restricted |z StatID:(DE-HGF)0599 |u https://juser.fz-juelich.de/record/904372/files/1-s2.0-S0197458021002086-main.pdf |
| 856 | 4 | _ | |y OpenAccess |z StatID:(DE-HGF)0510 |u https://juser.fz-juelich.de/record/904372/files/FZJ-2021-05942_Unique%20regional%20patterns_Pfeil.docx |
| 856 | 4 | _ | |y Restricted |u https://juser.fz-juelich.de/record/904372/files/FZJ-2021-05942_Unique%20regional%20patterns_Pfeil_Appendix%20A.docx |
| 856 | 4 | _ | |y Restricted |u https://juser.fz-juelich.de/record/904372/files/FZJ-2021-05942_Unique%20regional%20patterns_Pfeil_Appendix%20B.docx |
| 856 | 4 | _ | |y Restricted |u https://juser.fz-juelich.de/record/904372/files/FZJ-2021-05942_Unique%20regional%20patterns_Pfeil_Appendix%20C.docx |
| 909 | C | O | |o oai:juser.fz-juelich.de:904372 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany. Electronic address: julia.pfeil@uk-koeln.de. |0 I:(DE-HGF)0 |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany; Research Center Juelich, Institute for Neuroscience and Medicine II, Molecular Organization of the Brain, Juelich, Germany. |0 I:(DE-HGF)0 |b 1 |6 P:(DE-Juel1)178642 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn/Cologne, Germany |0 I:(DE-HGF)0 |b 2 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany; German Center for Neurodegenerative Diseases, Bonn/Cologne, Germany; University of Cologne, University Hospital of Cologne, Department of Neurology, Cologne, Germany |0 I:(DE-HGF)0 |b 3 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)177611 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany; Research Center Juelich, Institute for Neuroscience and Medicine II, Molecular Organization of the Brain, Juelich, Germany; German Center for Neurodegenerative Diseases, Bonn/Cologne, Germany |0 I:(DE-HGF)0 |b 4 |6 P:(DE-Juel1)177611 |
| 910 | 1 | _ | |a Department of Nuclear Medicine, Multimodal Neuroimaging Group, University of Cologne, University Hospital of Cologne, Cologne, Germany |0 I:(DE-HGF)0 |b 5 |6 P:(DE-Juel1)166265 |
| 910 | 1 | _ | |a Alzheimer's Disease Neuroimaging Initiative |0 I:(DE-HGF)0 |b 6 |6 P:(DE-HGF)0 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5253 |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5254 |x 1 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-01-28 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEUROBIOL AGING : 2019 |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-01-28 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-28 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-01-28 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-01-28 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-28 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2021-01-28 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-28 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-2-20090406 |k INM-2 |l Molekulare Organisation des Gehirns |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-2-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|